Penpulimab

(Synonyms: AK105)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Penpulimab (AK105) is an anti-PD-1 monoclonal antibody that blocks PD-1/PD-L1 signaling. Penpulimab enhances T cell activation and cytokine secretion, including increased production of IL-2 and IFN-γ. Penpulimab shows in vivo antitumor activity in mouse tumor models. Penpulimab can be used in research related to metastatic nasopharyngeal carcinoma, colorectal adenocarcinoma, and relapsed or refractory classical Hodgkin lymphoma.

For research use only. We do not sell to patients.

  • Purity : 98.80%
  • CAS No.: 2350298-92-7
  • Molecular Weight:145.14 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Penpulimab

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00